News
-
Stroke risk reduction
Friday | Apr 27 2018NEW research out of Monash University and the Karolinska Institutet has identified a potential new benefit of a commonly-used treatment for Alzheimer's disease.
-
Shire Takeda deal
Friday | Apr 27 2018JAPANESE pharmaceutical firm Takeda has agreed to pay about $84 billion for Irish drugmaker Shire.
-
TGA 70% in balance
Friday | Apr 27 2018AROUND 70% of stakeholders who responded to the Therapeutic Goods Administration 2016-17 TGA Stakeholder Survey indicated that they felt that the TGA was balancing risks appropriately as well as managing them proportionately.
-
Eagle shakes it up
Friday | Apr 27 2018ASX-LISTED Eagle Health Holdings has reported first quarter sales remain "on budget" driven by strong ongoing growth in protein powders and amino acid ranges.
-
Ulcer investigation
Friday | Apr 27 2018THE Federal Government has announced $1.5 million in funding to help better understanding of the flesh-eating Buruli ulcer and reduce its spread within Australia.
-
Dispensary Corner
Friday | Apr 27 2018
27 Apr 18SURE you can make a tasty sausage feast out of almost any part of a cow, pig or sheep when mixed with the right ingredients, but this might be pushing the envelope a little.
-
NanaBis available on MCMP
Thursday | Apr 26 2018COMMUNITY pharmacies are being invited to open accounts with Medlab Clinical in order to access the company's new NanaBis oromucosal pain spray, which is available via the Medicinal Cannabis Medicines Portal (MCMP) effective from today.
-
SHPA urges recognition
Thursday | Apr 26 2018THE Society of Hospital Pharmacists of Australia says there is no question that the scope of work of pharmacists is expanding - contradicting the position held by the Pharmacy Guild which opposes pay rises for pharmacists under a "work value claim" sought by union group APESMA (PD 24 Apr).
-
Guardian private label challenge
Thursday | Apr 26 2018GUARDIAN Pharmacy has launched a national "sales challenge" which will empower member pharmacies to support their local communities.
-
Blackmores ramps capacity
Thursday | Apr 26 2018BLACKMORES has announced a strategic acquisition of 100% of the Catalent Australia tablet and soft-gel capsule manufacturing facility in Braeside, Vic, for $43.2 million (PD breaking news Tue), expanding the company's ability to respond to changing market conditions.
